The research behind U: The Mind Company.
Peer-reviewed research, clinical trial data, and our full safety profile, all publicly traceable.
Parkinson's Disease
RESTORE Trial · Preprint · March 2026 · n=26
RESTORE Trial Results
Alzheimer's Disease
Peer-Reviewed · IntechOpen 2024 · n=5 · 12 weeks
Frontal Lobe Electrical Stimulation Enhances Connectivity in Alzheimer's Disease Networks: Evidence from rs-fMRI
Safety Profile
Most common side effect: mild, transient tingling at the electrode sites.
All Publications
Publication
The Biological Basis of Parkinson's Disease.
Peer-Reviewed | IntechOpen 2024
Frontal Lobe Electrical Stimulation Enhances Connectivity in Alzheimer's Disease Networks: Evidence from rs-fMRI.
View →Publication
Advanced Computer Vision and Signal Processing for Quantitative Tremor and Gait Analysis in Parkinson's Disease: A Case Study.
Publication
Toward EEG Digital Twins: Channel-wise Nonlinear State Estimation with the Unscented Kalman Filter and Jansen-Rit Model.
Publication
Behavioral Biomarkers for Parkinson's Disease: Bradykinesia, REM Sleep Behavior Disorder, and Hyposmia as Key Clinical Indicators.
Publication
The Role of PRKN Biallelic Loss-of-Function Variants in Parkinson's Disease: A Comprehensive Review.
Publication
Alpha-Synuclein Seed Amplification Assay (alphaSyn-SAA) in Parkinson's Disease: A Transformative Cellular Biomarker for Early Detection and Disease Monitoring.
Explore our technology
Learn more about how am-tPRNS works and the science behind our devices.